Skip to Main Content

Paper Details

End of induction patient reported outcomes predict clinical remission and endoscopic improvement with vedolizumab and adalimumab in ulcerative colitis.
Scand J Gastroenterol
1
2023
Author NameAffiliation
Parambir S DulaiNorthwestern University
Neeraj NarulaDepartment of Medicine (Division of Gastroenterology) and Farncombe Family Digestive Health Research Institute, McMaster University
  • 1 - 2

Datasets

Release 1.2